Tilomisole
From Wikipedia, the free encyclopedia
| Names | |
|---|---|
| Preferred IUPAC name
[3-(4-Chlorophenyl)[1,3]thiazolo[3,2-a][1,3]benzimidazol-2-yl]acetic acid | |
| Identifiers | |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
| KEGG | |
PubChem CID |
|
| UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
| Properties | |
| C17H11ClN2O2S | |
| Molar mass | 342.80 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Tilomisole (WY-18,251) is an experimental drug which acts as an immunomodulator and has been studied for the treatment of some forms of cancer.[1][2]
